Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva's ProAir HFA with dose counter receives US FDA approval
Pharmabiz
Saturday, March 10, 2012 - 6:48pm
tags:
Teva Pharmaceuticals, ProAir HFA
BioMarin completes phase III trial enrollment for N-acetylgalactosamine 6-sulfatase for MPS IVA
Pharmabiz
Saturday, March 10, 2012 - 6:47pm
tags:
Biomarin, mucopolysaccharidosis, Morquio A Syndrome, BMN-110
Boehringer Ingelheim, Lilly launch new oral type 2 diabetes drug Jentadueto in US
Pharmabiz
Saturday, March 10, 2012 - 6:44pm
tags:
Boehringer Ingelheim, Eli Lilly, Jentadueto, diabetes, type 2 diabetes
EntreMed sees earnings, revenue drop
Daily Record, MD
Saturday, March 10, 2012 - 6:42pm
tags:
EntreMed
Abbott Vs. Peers: A Strong Buy Candidate
Seeking Alpha
Saturday, March 10, 2012 - 6:40pm
tags:
Abbott Laboratories
Shire Initiates Trials for Vyvanse
Zacks
Saturday, March 10, 2012 - 6:39pm
tags:
Shire, Vyvanse, ADHD
Merck: Strong Pipeline, Steady Dividends
Seeking Alpha
Saturday, March 10, 2012 - 6:38pm
tags:
Merck
Bayer not hungry for big acquisitions: CEO in paper
Yahoo/Reuters
Saturday, March 10, 2012 - 4:11pm
tags:
Bayer
Approval Likely, but Details Still Important
Motley Fool
Saturday, March 10, 2012 - 4:10pm
tags:
HIV, Gilead Sciences
U.S. nixes tentative $1 bln settlement with J&J -WSJ
Reuters
Saturday, March 10, 2012 - 4:08pm
tags:
JNJ, legal, Risperdal
Pfizer - Offer for Animal Health Business
Yahoo/Investor's Business Daily
Saturday, March 10, 2012 - 4:07pm
tags:
Pfizer, Bayer, veterinary medicine, animal health
AstraZeneca - generic Seroquel ruling
Yahoo/Investors Business Daily
Saturday, March 10, 2012 - 4:05pm
tags:
Seroquel, generics, AstraZeneca
Anthera halts late-stage heart drug trial, shares tank
Reuters
Saturday, March 10, 2012 - 4:03pm
tags:
Anthera, VISTA-16, acute coronary syndrome
Peregrine Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Seeking Alpha
Saturday, March 10, 2012 - 4:01pm
tags:
Peregrine Pharmaceuticals, earnings
DaVita Collaborates with 3SBio
Yahoo/Zacks
Saturday, March 10, 2012 - 3:57pm
tags:
DaVita, 3SBio, anemia
Halozyme Q4 results fall short
Yahoo/Investor's Business Daily
Saturday, March 10, 2012 - 3:56pm
tags:
Halozyme
How To Play Chelsea Therapeutics
Seeking Alpha
Saturday, March 10, 2012 - 3:54pm
tags:
Chelsea Therapeutics
Oncothyreon CEO: Investors had ‘unrealistic expectations’
MarketWatch
Saturday, March 10, 2012 - 3:52pm
tags:
cancer vaccines, Stimuvax, Oncothyreon, vaccines
Geron Misses Estimates
Yahoo/Zacks
Saturday, March 10, 2012 - 3:50pm
tags:
Geron
Aastrom Raises Cash To Fund Pivotal Trial
TheStreet.com
Friday, March 9, 2012 - 4:23pm
tags:
Aastrom Biosciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.